DGAP-Adhoc: RHÖN-KLINIKUM AG: Invitation for the purchase of Notes, termination of the rating contract with Moody's as of 30 April 2014

        Print
| Source: EQS Group AG
RHÖN-KLINIKUM AG  / Key word(s): Bond

27.03.2014 07:43

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE
UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE
UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA (THE "UNITED STATES")
OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT.

March 27, 2014

Invitation for the purchase of Notes, termination of the rating contract
with Moody's as of 30 April 2014

The Company resolved to invite the holders of any and all of its
outstanding EUR 400,000,000 3.875 per cent. Notes due 2016 (ISIN:
XS0491047154) (the "Notes") to tender for the purchase for cash any and all
of the Notes. The Company is under no obligation to accept any Notes
tendered in the Invitation. If Notes validly tendered for purchase pursuant
to the Invitation by a Noteholder are accepted for purchase by the Company,
the Company will pay, or procure to be paid, on the Settlement Date to the
Noteholder the Purchase Price (106.10 per cent. of the specified
denomination (equal to EUR 1,061 per Note)) due to that Noteholder. The
Company will also pay accrued interest. The invitation begins today, 27
March 2014, and is expected to expire at 5.00 p.m. CEST on 16 April 2014.
The settlement of the Notes is expected to be on 24 April 2014.

The Company will terminate its long-term cooperation with the rating agency
Moody's Investors Service in the upcoming month. The Company (current
rating: Baa3 (Outlook: negative)) has terminated its rating contract with
effect of 30 April 2014 and currently does not intend to mandate any other
public ratings.

This decision is based on a cost-benefit analysis following the transaction
with Fresenius-Helios. With its changed financial profile, its stable
business model and its outstanding reputation among banks and capital
markets, the Company is well prepared to obtain future financing without a
public rating at attractive conditions .

The invitation referenced herein is not being made, directly or indirectly,
in or into the United States by use of the mails or by any means or
instrumentality (including, without limitation, e-mail, facsimile
transmission, telephone and the internet) of interstate or foreign
commerce, or of any facility of a national securities exchange of the
United States and the Invitation cannot be accepted by any such use, means,
instrumentality or facility or from within the United States.

This notice does not constitute or form a part of any offer or solicitation
to purchase or subscribe for securities in the United States.

Contact:
RHÖN-KLINIKUM AG

Dr. Kai G. Klinger
Head of Investor Relations and Corporate Finance
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Telefon: +49 (0) 9771 65-1318
Telefax: +49 (0) 9771 99-1736
E-Mail: kai.klinger@rhoen-klinikum-ag.com

Achim Struchholz
Head of Corporate Communications
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Telefon: +49 (0) 9771 65-1327
Telefax: +49 (0) 9771 65-1820
E-Mail: kommunikation@rhoen-klinikum-ag.com


27.03.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      RHÖN-KLINIKUM AG
              Schlossplatz 1
              97616 Bad Neustadt a.d.Saale
              Germany
Phone:        +49 (0)9771 - 65-0
Fax:          +49 (0)9771 - 97 467
E-mail:       rka@rhoen-klinikum-ag.com
Internet:     www.rhoen-klinikum-ag.com
ISIN:         DE0007042301
WKN:          704230
Indices:      MDAX
Listed:       Regulierter Markt in Frankfurt (Prime Standard), München;
              Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------